While, clustered DLL1 therapy results in significant enhancement of tumor antigen-specific T cell immune responses and memory, remarkably increased tumor infiltration by T cells, attenuated tumor vascularization, and suppression of tumor growth and produced remarkably enhanced progression-free survival17. The gene discussed is DLL1; the disease is neoplasm.